Introduction-Nitric oxide (NO) signaling regulates many biological processes in skeletal muscle, wherein aberrant signaling contributes to myopathic conditions (e.g., Duchenne muscular dystrophy). NO has been shown to play a role in muscle regeneration after injury. However, less is known about its role during injury. In this study we aimed to determine whether NO synthase (NOS) inhibition exacerbates functional deficits immediately after the performance of eccentric contractions.
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METHODS
All animal care and use procedures were approved by our institutional animal care and use committee. Extensor digitorum longus (EDL) muscles were isolated from adult (age 4-5 months of age), male, wild-type mice (C57BL/6) and were tested in an in vitro organ bath system. 16 Muscles underwent a battery of functional tests (Fig. 1A ) in Krebs-Ringer bicarbonate buffer at 35°C with 95% O 2 -CO 2 balanced air perfused continuously. In some experiments, N ω -nitro-L-arginine methylester hydro-chloride (L-NAME), a non-specific NOS inhibitor, was added to the Krebs-Ringer buffer at a final concentration of 10 mM.
(Millimolar concentrations of L-NAME have been shown to modulate contractility of skeletal muscle 4 and NO-mediated events in other organ systems. 17 ) Muscle resting tension was initially set to ~4.5 mN to correspond to anatomical muscle length (L o ). 18 Muscles were stimulated directly by applying trains of 0.2-ms pulses with a supramaximal voltage. Isometric specific force was measured as a function of stimulation frequency (F-f: 10-300 HZ; 200-ms train), 16 before and after L-NAME administration and after the performance of 10 eccentric or isometric (300 HZ) contractions, with a 3-minute rest between contractions. During the eccentric contractions, the muscle was shortened to 90% and then lengthened to 110% of L o at 1.5 muscle lengths per second, while it was stimulated (300 Z) for 133 ms. 18 Muscle wet weight and L o for all muscles was 11.6 ± 0.21 mg and 1.37 ± 0.01 cm, respectively. The stimulation frequency corresponding to half the amplitude of force (Freq 50 ) of the normalized F-f curve was determined using a four-parameter Hill equation. 16 Statistical differences were assessed with one-and two-way analyses of variance (ANOVAs) and t-tests; α was set at 0.05.
RESULTS
Prior to injury, L-NAME administration depressed peak isometric force (P o ) by ~10% [ Fig.  1C , E, G and I; L-NAME (n = 4), P = 0.035; vs. <-1% in Krebs (n = 4), P = 0.985] but elevated twitch force (P t ) by ~8% (P = 0.031). During the eccentric injury protocol, initial peak eccentric force was similar between L-NAME and Krebs muscles, but L-NAME promoted a greater loss of eccentric force ( Fig. 1B ; L-NAME vs. Krebs: ~-38 vs. -24%; P = 0.041). Immediately after eccentric contractions, isometric force was reduced across all frequencies by 44-52% in the presence of L-NAME (Fig. 1H) and to a lesser extent (24-37%) for Krebs (Fig. 1D) . Control L-NAME muscles (n = 2) that performed 10 isometric instead of eccentric contractions demonstrated an ~8% reduction in isometric force during the protocol and a corresponding ~9% deficit in P o from pre-to post-injury (P = 0.094), similar to findings we made previously with EDL muscle with Krebs only. 16 Freq 50 increased significantly from pre-to postinjury for Krebs ( Fig. 1F ; 92 ± 2 HZ vs. 106 ± 1 Z, P = 0.008), but not for L-NAME muscles ( Fig. 1J ; 87 ± 2 vs. 97 ± 4 Z, P = 0.162).
DISCUSSION
We have demonstrated that L-NAME, an inhibitor of NOS, exacerbates functional deficits during and after eccentric contractions in healthy murine muscle, suggesting that NOS serves to partially protect skeletal muscle from injury. It is possible that the high concentration of L-NAME used in this study may have non-specific biological effects, 19 such as blocking of muscarinic acetylcholine receptor signaling. 20 However, the effect of muscarinic acetylcholine receptor activity on P o is incongruous with our findings with L-NAME. 21 Further, the contractile phenotype mediated by millimolar concentrations of L-NAME 4 ( Fig. 1 ) is similar to that of nNOS -/-muscle, 4 suggesting that, in a whole-muscle preparation, millimolar L-NAME primarily inhibits NOS.
Because these experiments were performed in vitro and were thus largely devoid of macrophages and hence iNOS activity, it is likely that nNOSμ serves to protect muscle from eccentric muscle injury. This is of interest when compared with findings showing that nNOS -/-mice did not exhibit significant differences in regeneration from wild-type mice after a myotoxic injury, 22 whereas non-specific pharmacological inhibition of NOS impeded inflammation 23 and regeneration. 7 The findings from those studies and this study support the supposition of Lynch and colleagues, 22 who showed that nNOSμ plays a critical role in protecting skeletal muscle from injury during the injury bout, whereas iNOS primarily mediates regeneration thereafter.
A remaining question is how NO signaling protects healthy skeletal muscle from injury during eccentric contractions. Immediate functional deficits after eccentric contractions are primarily due to E-C uncoupling, [12] [13] [14] likely the result of triadic protein damage caused by physical stress. 16, 24 However, we did not observe a rightward shift in the force-frequency curve (i.e., Freq 50 ) after injury with NOS inhibition, suggesting that the increased force deficits observed may have been due to increased damage of force-bearing proteins (e.g., titin, dystrophin, or desmin). Although the performance of eccentric contractions has been shown to immediately increase cytosolic Ca 2+,12,13 which may increase proteolysis, our laboratory has demonstrated in otherwise healthy muscle using a similar injury protocol that immediate functional deficits are not improved via extracellular Ca 2+ manipulation, 25 blockade of stretch-activated Ca 2+ channels, 16 or inhibition of calpain. 18 Collectively, these findings suggest that NO signaling in response to eccentric contractions protects healthy skeletal muscle from excessive damage, potentially by attenuating proteolytic activity. In myopathic conditions in which NO signaling is disrupted, this protective effect is likely diminished and results in a greater propensity for injury with high mechanical stress.
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